Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-03

FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for galantamine hydrobromide (Sun Pharmaceutical Industries, Inc.) under ANDA090178, resulting in an approved generic pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)

Snippet

SUPPL AP for GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)